Login Preferences
About News Publications Statistics Downloads API Guide License How to use Preferences
bn:00848690n
Noun Concept
Categories: World Health Organization essential medicines, Fluoropyrimidines, Organofluorides, Drugboxes which contain changes to watched fields, Pyrimidine antagonists
EN
gemcitabine  4-amino-1-((2R,4R,5R)-3,3-Difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one  DFDC  2',2'-Difluorodeoxycytidine  2'-Deoxy-2',2'-difluorocytidine
EN
Gemcitabine, sold under the brand name Gemzar, among others, is a chemotherapy medication used to treat cancers. Wikipedia
Definitions
Relations
Sources
EN
Gemcitabine, sold under the brand name Gemzar, among others, is a chemotherapy medication used to treat cancers. Wikipedia
Chemical compound Wikidata
IS A
compound
medicine
essential medicines
antiviral
bactericide
MEDICAL CONDITION TREATED
lymphoma
mycosis fungoides
bladder cancer
diffuse large B-cell lymphoma
non-small-cell lung cancer
+6 relations
PREGNANCY CATEGORY
Australian pregnancy category D
SUBJECT HAS ROLE
immunosuppressant
DNA polymerase inhibitors
radiosensitizer
enzyme inhibitor
Wikipedia
EN
gemcitabine
Wikidata
EN
gemcitabine
Wikipedia Redirections
EN
ATC code L01BC05, ATCvet code QL01BC05, C9H11F2N3O4, DDFC, DFDC, DFdC, GemCarbo chemotherapy, Gemcin, Gemcitabine hydrochloride, Gemcitabine Hydrochloride, Gemcitabinum, Gemicitabine, Gemtro, Gemzar, Infugem
Wikidata Alias
EN
2',2'-Difluorodeoxycytidine, 2'-Deoxy-2',2'-difluorocytidine, Gemcitabin, Gemcitabina, Gemcitabine, gemcitabine hydrochloride, Gemcitabinum, Gemzar®, 4-amino-1-((2R,4R,5R)-3,3-Difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one, 4-amino-1-((2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one

Please note that, in order to improve your browsing experience on this website, BabelNet® uses various types of cookies, including: browsing functionality, performance and statistical cookies.

By continuing to browse the site you are agreeing to our use of cookies. OK

License